Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and …
Medical - Instruments & Supplies
DE, Jena [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -16.71 | 82.59 | 99.16 | |
| Graham Fair Price | 31.30 | 18.61 | 14.18 | |
| PEG | -54.45 | 0.33 | -0.73 | |
| Price/Book | 10.85 | 3.13 | 2.82 | |
| Price/Cash Flow | -91.97 | 169.29 | -2107.39 | |
| Prices/Earnings | -39.64 | 26.28 | 43.55 | |
| Price/Sales | -0.07 | 11.02 | 11.02 | |
| Price/FCF | -91.97 | 169.29 | -2107.39 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | -8.01 | 0.50 | 0.54 | |
| Operating Margin | inf | 0.00 | 0.10 | |
| ROA | 100.00 | 0.02 | 0.00 | |
| ROE | 0.02 | 0.03 | 83.64 | |
| ROIC | 0.02 | 0.00 | inf | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | 0.00 | -1.00 | inf | |
| Dividends QOQ | -1.00 | 0.00 | inf | |
| EBIT QOQ | -0.50 | -1.00 | -101.08 | |
| EPS QOQ | -0.60 | 0.79 | 32.52 | |
| FCF QOQ | 0.87 | 14.37 | 1560.79 | |
| Revenue QOQ | -0.43 | 0.07 | -82.65 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Balanced
Fundamentals
Leverage & Liquidity
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 0.00 | 166.68 | 100.00 | |
| Days Sales Outstanding (DSO) | 0.00 | 0.00 | 0.00 | |
| Inventory Turnover | 0.00 | 0.54 | 100.00 | |
| Debt/Capitalization | 0.00 | 0.00 | 0.00 | |
| Quick Ratio | 0.00 | 1.19 | 100.00 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Book Value | 0.00 | 22.92 | 100.00 | |
| Cash | 0.17 | 0.23 | 32.24 | |
| Capex | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | -0.03 | 0.42 | 1236.94 | |
| Revenue | 6.01 | 6.46 | 7.47 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Best
Fundamentals
Financial Health
06 - Financial Health ·
Bad